OKYO PHARMA LTD
OKYO · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $1.47
- Today’s Low
- $1.41
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.46
- Previous Close
- $1.44
- Volume
- 70.36K
- Market Cap
- $75.57M
- P/E Ratio
- --
- EPS
- $-0.23
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 35A ALBEMARLE ST, LONDON, UNITED KINGDOM, W1S 4JE
- Country
- GB
- Listing Date
- 2018-07-17
- Fiscal Year End
- March
- Shares Outstanding
- 52.48M
- CIK
- 0001849296
- Website
- okyopharma.com
OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye pain in the UK. The company is headquartered in London, the United Kingdom.
Financial Metrics
Revenue
2026-06-30
--
2025-09-30
--
2025-06-30
--
2025-03-31
--
Operating Expenses
2026-06-30
$6.4M
2025-09-30
$2.79M
2025-06-30
$4.17M
2025-03-31
$4.17M
Net Income
2026-06-30
-$6.36M
2025-09-30
-$2.58M
2025-06-30
-$2.02M
2025-03-31
-$2.02M
Net Profit Margin
2026-06-30
--
2025-09-30
--
2025-06-30
--
2025-03-31
--
Earnings Per Share
2026-06-30
--
2025-09-30
--
2025-06-30
$-0.06
2025-03-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$6.4M
2025-09-30
-$2.79M
2025-06-30
-$3.75M
2025-03-31
-$3.75M
Effective Tax Rate
2026-06-30
-0.12%
2025-09-30
0%
2025-06-30
47.66%
2025-03-31
47.66%
| Item | 2026-06-30 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | -- | -- | -- | -- |
| Operating Expenses | $6.4M | $2.79M | $4.17M | $4.17M |
| Net Income | -$6.36M | -$2.58M | -$2.02M | -$2.02M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | -- | -- | $-0.06 | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$6.4M | -$2.79M | -$3.75M | -$3.75M |
| Effective Tax Rate | -0.12% | 0% | 47.66% | 47.66% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.